Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: Analysis at the haplotype level

Journal of Korean Medical Science

Volumn 23, Issue 5, 2008, Pages 838-844

  Sung, Won Cho ^a   Jae, Youn Cheong ^a   Young, Su Ju ^b   Do, Hoon Oh ^b   Young, Ju Suh ^c   Kyung, Wha Lee ^b  

^a Ajou University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

Clearance; DQB1*0609; DRB1*1302; Hepatitis B virus; Persistence

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; BIOLOGICAL MODEL; GENE; GENETICS; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; KOREA; REMISSION; TREATMENT OUTCOME; VIROLOGY;

ALLELES; GENES, MHC CLASS II; HAPLOTYPES; HEPATITIS B; HEPATITIS B VIRUS; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KOREA; MODELS, GENETIC; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 56049121741     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.5.838     Document Type: Article

References (27)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
2. Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002; 62(Suppl 1): 18-23.
3. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001; 34: 1225-41.
4. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2: 43-50.
5. Urbani S, Boni C, Amadei B, Fisicaro P, Cerioni S, Valli MA, Missale G, Ferrari C. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection. Hepatology 2005; 41: 826-31.
6. Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AV. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci USA 1995; 92: 6567-71.
7. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002; 17: 457-62.
8. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-3.
9. Hwang SH, Sohn YH, Oh HB, Hwang CY, Lee SH, Shin ES, Lee KJ. Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans. Arch Pathol Lab Med 2007; 131: 117-21.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
11. Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes. Tissue Antigens 1999; 53: 486-97.
12. Van der Zwan A, Griffith B, Rozemuller E, Williams T, Tilanus MG. Sequence-based typing for HLA-DQB1 strategy for ABI sequencing equipment. In: Tilanus MGJ, Hansen JA, Hurley CK, eds. IHWG Technical Manual. Seattle: International Histocompatibility Working Group, 2000; TM12A1-4.
13. Van der Zwan A, Rozemuller E, Tilanus MG. Sequence-based typing for HLA-DPB1 strategy for ABI equipment. In: Tilanus MGJ, Hansen JA, Hurley CK, eds. IHWG Technical Manual. Seattle: International Histocompatibility Working Group; 2000; TM14A1-4.
14. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
15. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005; 65: 437-47.
16. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-9.
17. Höhler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Löhr HF, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997; 26: 503-7.
18. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77: 12083-7.
19. Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Grüner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S, Pape GR. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998; 113: 244-51.
20. Cao T, Desombere I, Vanlandschoot P, Sallberg M, Leroux-Roels G. Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen Virol 2002; 83: 3023-33.
21. Van Hattum J, Schreuder GM, Schalm S. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987; 7: 11-4.
22. Begovich AB. HLA-DPA1, -DPB1, DQA1, and -DQB1 allele frequencies in a population from Gambia. Hum Immunol 2004; 65: 944-5.
23. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 1999; 179: 1004-6.
24. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol 2003; 9: 2221-5.
25. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-5.
26. Yang G, Liu J, Han S, Xie H, Du R, Yan Y, Xu D, Fan D. Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens 2007; 69: 170-5.
27. Milner CM, Campbell D, Trowsdale J. Molecular genetics of the human major histocompatibility complex. In: Lechler R, Warrens A, eds. HLA in health and disease. London: Academic press 2000; 35-50.